Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 14 of 124)
- Relevance
  Sort by

Febrile Neutropenia - Pipeline Insight, 2024

 Clinical Trials
April 2024
65 Pages
Global

From

€1043EUR$1,050USD£867GBP

€1490EUR$1,500USD£1,239GBP

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

 Report
December 2023
799 Pages
Global

From

€4768EUR$4,799USD£3,964GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

 Report
September 2024
750 Pages
Global

From

€3969EUR$3,995USD£3,300GBP

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024

 Report
September 2024
250 Days
Global

From

€3969EUR$3,995USD£3,300GBP

Glioblastoma Multiforme Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Antibacterial Drugs Market by Routes of Administration, Drug Class, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
182 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Beta Lactam & Beta Lactamase Inhibitors Market by Drug Class, Disease, Route of Administration, Distribution Channels, End User, Drug Type - Global Forecast 2025-2030

 Report
October 2024
185 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
178 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Non-Small Cell Lung Cancer (NSCLC) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

Lung Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

Neuroblastoma Drugs Market By Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
January 2024
256 Pages
Global

From

€3547EUR$3,570USD£2,949GBP

Thyroid Cancer Drugs Market by Drug Type, Mode of Administration, Stage of Disease, Cancer Type, End User - Global Forecast 2025-2030

 Report
October 2024
199 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Global Cancer Vaccine Market & Clinical Trials Outlook 2028

 Report
July 2022
600 Pages
Global

From

€3278EUR$3,300USD£2,726GBP

Lung Cancer Therapeutics Market Report by Therapy, Cancer Type, Distribution Channel, and Region 2024-2032

 Report
July 2024
137 Pages
Global

From

€3873EUR$3,899USD£3,221GBP

Hepatitis B Virus Infection - Global Drug Forecast and Market Analysis to 2029

 Report
March 2021
132 Pages
Global

From

€10923EUR$10,995USD£9,082GBP

Glioblastoma Multiforme Treatment Market Report by Drug Type, Route of Administration, Type of Molecule, Distribution Channel, and Region 2024-2032

 Report
April 2024
138 Pages
Global

From

€3873EUR$3,899USD£3,221GBP

Non-Small-Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
180 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
March 2023
545 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

2,463 Results (Page 14 of 124)
- 1
- 12
- 13
- 14
- 15
- 16

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.